Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 7Carcinoma, Hepatocellular 5Prostatic Neoplasms 3Liver Neoplasms 3Kidney Neoplasms 3Head and Neck Neoplasms 2Thyroid Neoplasms 1Sleep Apnea, Obstructive 1Sarcoma 1Rhinitis, Allergic, Seasonal 1Renal Insufficiency, Chronic 1Recurrence 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Ovarian Neoplasms 1Mesothelioma 1Melanoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hypertension, Pulmonary 1Emphysema 1Cystic Fibrosis 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Bronchiectasis 1Asthma 1Asbestosis 1

Interventions

Nivolumab 74Sunitinib 73pembrolizumab 49Everolimus 39Sorafenib 36Bevacizumab 36Axitinib 36cabozantinib 35Radiosurgery 33Ipilimumab 33pazopanib 32Magnetic Resonance Spectroscopy 27Interleukin-2 27aldesleukin 23Specimen Handling 22Cyclophosphamide 21lenvatinib 20fludarabine phosphate 17Radiotherapy 16Interferon-alpha 15Peripheral Blood Stem Cell Transplantation 14Gemcitabine 14Biopsy 14temsirolimus 13Nephrectomy 13durvalumab 11Immunohistochemistry 11CTLA-4 Antigen 11Blood Specimen Collection 11Capecitabine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Renal Cell × perflutren × Clear all
NCT01062178 2016-03-08

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

University Health Network, Toronto

Phase 2 Completed
167 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡